vs
PDF SOLUTIONS INC（PDFS）与RIGEL PHARMACEUTICALS INC（RIGL）财务数据对比。点击上方公司名可切换其他公司
RIGEL PHARMACEUTICALS INC的季度营收约是PDF SOLUTIONS INC的1.1倍（$69.8M vs $62.4M），RIGEL PHARMACEUTICALS INC净利率更高（384.0% vs -0.1%，领先384.1%），PDF SOLUTIONS INC同比增速更快（24.6% vs 21.2%），过去两年RIGEL PHARMACEUTICALS INC的营收复合增速更高（53.7% vs 22.9%）
PDF Solutions Inc是一家总部位于美国加利福尼亚州圣克拉拉的跨国企业，主营软件业务与工程技术服务，目前在纳斯达克交易所挂牌上市，股票代码为PDFS。
Rigel制药是一家临床阶段生物技术企业，专注于研发及商业化针对自身免疫性疾病、炎症性疾病与血液疾病的靶向小分子疗法，核心市场位于美国，旗下已获批产品可治疗成人免疫性血小板减少症，致力于满足未被覆盖的临床医疗需求。
PDFS vs RIGL — 直观对比
营收规模更大
RIGL
是对方的1.1倍
$62.4M
营收增速更快
PDFS
高出3.4%
21.2%
净利率更高
RIGL
高出384.1%
-0.1%
两年增速更快
RIGL
近两年复合增速
22.9%
损益表 — Q4 FY2025 vs Q4 FY2025
| 指标 | | |
|---|---|---|
| 营收 | $62.4M | $69.8M |
| 净利润 | $-48.0K | $268.1M |
| 毛利率 | 72.9% | 91.5% |
| 营业利润率 | 5.5% | 33.2% |
| 净利率 | -0.1% | 384.0% |
| 营收同比 | 24.6% | 21.2% |
| 净利润同比 | -108.9% | 1769.2% |
| 每股收益（稀释后） | $0.00 | $14.11 |
绿色 = 该指标领先。财年不对齐时期间可能不同
8季度营收与利润趋势
并排季度历史对比，按日历期对齐，财年错位的公司也能正确匹配
营收PDFSRIGL
| Q4 25 | $62.4M | $69.8M | ||
| Q3 25 | $57.1M | $69.5M | ||
| Q2 25 | $51.7M | $101.7M | ||
| Q1 25 | $47.8M | $53.3M | ||
| Q4 24 | $50.1M | $57.6M | ||
| Q3 24 | $46.4M | $55.3M | ||
| Q2 24 | $41.7M | $36.8M | ||
| Q1 24 | $41.3M | $29.5M |
净利润PDFSRIGL
| Q4 25 | $-48.0K | $268.1M | ||
| Q3 25 | $1.3M | $27.9M | ||
| Q2 25 | $1.1M | $59.6M | ||
| Q1 25 | $-3.0M | $11.4M | ||
| Q4 24 | $539.0K | $14.3M | ||
| Q3 24 | $2.2M | $12.4M | ||
| Q2 24 | $1.7M | $-1.0M | ||
| Q1 24 | $-393.0K | $-8.2M |
毛利率PDFSRIGL
| Q4 25 | 72.9% | 91.5% | ||
| Q3 25 | 72.3% | 93.2% | ||
| Q2 25 | 71.2% | 95.6% | ||
| Q1 25 | 72.9% | 91.7% | ||
| Q4 24 | 68.3% | 89.9% | ||
| Q3 24 | 73.1% | 85.5% | ||
| Q2 24 | 70.6% | 92.4% | ||
| Q1 24 | 67.3% | 93.1% |
营业利润率PDFSRIGL
| Q4 25 | 5.5% | 33.2% | ||
| Q3 25 | 8.5% | 40.9% | ||
| Q2 25 | 2.2% | 60.1% | ||
| Q1 25 | -7.4% | 23.9% | ||
| Q4 24 | 1.0% | 28.9% | ||
| Q3 24 | 4.6% | 25.4% | ||
| Q2 24 | 0.6% | 1.2% | ||
| Q1 24 | -4.7% | -23.6% |
净利率PDFSRIGL
| Q4 25 | -0.1% | 384.0% | ||
| Q3 25 | 2.3% | 40.2% | ||
| Q2 25 | 2.2% | 58.6% | ||
| Q1 25 | -6.3% | 21.5% | ||
| Q4 24 | 1.1% | 24.9% | ||
| Q3 24 | 4.8% | 22.5% | ||
| Q2 24 | 4.1% | -2.8% | ||
| Q1 24 | -1.0% | -27.9% |
每股收益（稀释后）PDFSRIGL
| Q4 25 | $0.00 | $14.11 | ||
| Q3 25 | $0.03 | $1.46 | ||
| Q2 25 | $0.03 | $3.28 | ||
| Q1 25 | $-0.08 | $0.63 | ||
| Q4 24 | $0.01 | $0.82 | ||
| Q3 24 | $0.06 | $0.70 | ||
| Q2 24 | $0.04 | $-0.06 | ||
| Q1 24 | $-0.01 | $-0.47 |
资产负债表与财务实力
最新季度各公司的流动性、杠杆与账面价值一览
| 指标 | | |
|---|---|---|
| 现金及短期投资手头流动性 | $42.2M | $155.0M |
| 总债务越低越好 | $67.0M | $52.5M |
| 股东权益账面价值 | $271.0M | $391.5M |
| 总资产 | $418.7M | $513.6M |
| 负债/权益比越低杠杆越低 | 0.25× | 0.13× |
8季度趋势，按日历期对齐
现金及短期投资PDFSRIGL
| Q4 25 | $42.2M | $155.0M | ||
| Q3 25 | $35.9M | $137.1M | ||
| Q2 25 | $40.4M | $108.4M | ||
| Q1 25 | $54.1M | $77.1M | ||
| Q4 24 | $114.9M | $77.3M | ||
| Q3 24 | $120.2M | $61.1M | ||
| Q2 24 | $117.9M | $49.1M | ||
| Q1 24 | $122.9M | $49.5M |
总债务PDFSRIGL
| Q4 25 | $67.0M | $52.5M | ||
| Q3 25 | $67.6M | $60.0M | ||
| Q2 25 | $68.1M | $60.0M | ||
| Q1 25 | $68.7M | $60.0M | ||
| Q4 24 | — | $60.0M | ||
| Q3 24 | — | $60.0M | ||
| Q2 24 | — | $60.0M | ||
| Q1 24 | — | $60.0M |
股东权益PDFSRIGL
| Q4 25 | $271.0M | $391.5M | ||
| Q3 25 | $264.4M | $117.6M | ||
| Q2 25 | $257.5M | $81.9M | ||
| Q1 25 | $249.0M | $18.6M | ||
| Q4 24 | $246.0M | $3.3M | ||
| Q3 24 | $240.5M | $-14.6M | ||
| Q2 24 | $232.2M | $-29.9M | ||
| Q1 24 | $225.4M | $-31.7M |
总资产PDFSRIGL
| Q4 25 | $418.7M | $513.6M | ||
| Q3 25 | $406.4M | $242.5M | ||
| Q2 25 | $391.1M | $206.7M | ||
| Q1 25 | $390.0M | $176.0M | ||
| Q4 24 | $315.3M | $164.0M | ||
| Q3 24 | $307.4M | $139.4M | ||
| Q2 24 | $298.0M | $128.4M | ||
| Q1 24 | $286.8M | $126.5M |
负债/权益比PDFSRIGL
| Q4 25 | 0.25× | 0.13× | ||
| Q3 25 | 0.26× | 0.51× | ||
| Q2 25 | 0.26× | 0.73× | ||
| Q1 25 | 0.28× | 3.23× | ||
| Q4 24 | — | 18.25× | ||
| Q3 24 | — | — | ||
| Q2 24 | — | — | ||
| Q1 24 | — | — |
现金流与资本效率
扣除再投资后实际产生的现金。现金流比净利润更难造假
| 指标 | | |
|---|---|---|
| 经营现金流最新季度 | $17.3M | $22.0M |
| 自由现金流经营现金流 - 资本支出 | $7.5M | — |
| 自由现金流率自由现金流/营收 | 12.1% | — |
| 资本支出强度资本支出/营收 | 15.7% | — |
| 现金转化率经营现金流/净利润 | — | 0.08× |
| 过去12个月自由现金流最近4个季度 | $-8.6M | — |
8季度趋势，按日历期对齐
经营现金流PDFSRIGL
| Q4 25 | $17.3M | $22.0M | ||
| Q3 25 | $3.3M | $24.0M | ||
| Q2 25 | $-5.2M | $30.5M | ||
| Q1 25 | $8.6M | $-893.0K | ||
| Q4 24 | $1.6M | $14.5M | ||
| Q3 24 | $9.3M | $21.7M | ||
| Q2 24 | $684.0K | $302.0K | ||
| Q1 24 | $-1.9M | $-5.0M |
自由现金流PDFSRIGL
| Q4 25 | $7.5M | — | ||
| Q3 25 | $-2.9M | — | ||
| Q2 25 | $-13.8M | — | ||
| Q1 25 | $535.0K | — | ||
| Q4 24 | $-4.0M | — | ||
| Q3 24 | $5.1M | — | ||
| Q2 24 | $-4.6M | — | ||
| Q1 24 | $-3.9M | — |
自由现金流率PDFSRIGL
| Q4 25 | 12.1% | — | ||
| Q3 25 | -5.1% | — | ||
| Q2 25 | -26.6% | — | ||
| Q1 25 | 1.1% | — | ||
| Q4 24 | -8.0% | — | ||
| Q3 24 | 11.0% | — | ||
| Q2 24 | -11.1% | — | ||
| Q1 24 | -9.4% | — |
资本支出强度PDFSRIGL
| Q4 25 | 15.7% | — | ||
| Q3 25 | 10.8% | — | ||
| Q2 25 | 16.5% | — | ||
| Q1 25 | 17.0% | — | ||
| Q4 24 | 11.3% | — | ||
| Q3 24 | 9.0% | — | ||
| Q2 24 | 12.8% | — | ||
| Q1 24 | 4.9% | — |
现金转化率PDFSRIGL
| Q4 25 | — | 0.08× | ||
| Q3 25 | 2.54× | 0.86× | ||
| Q2 25 | -4.55× | 0.51× | ||
| Q1 25 | — | -0.08× | ||
| Q4 24 | 2.98× | 1.01× | ||
| Q3 24 | 4.20× | 1.75× | ||
| Q2 24 | 0.40× | — | ||
| Q1 24 | — | — |
财务流量对比
营收 → 毛利润 → 营业利润 → 净利润流向图
业务分部营收拆解
PDFS
| Volumebased | $38.0M | 61% |
| Other | $24.4M | 39% |
RIGL
暂无分部数据
